Skip to main content
Loading

ZWI Therapeutics

October 17, 2023
Franciscan B
Oncology
ZWI Therapeutics is a biotechnology company developing novel protein therapeutics linked to a novel polymer. The company's proprietary polymer technology reduces the immunogenicity of therapeutic proteins and significantly improves the pharmacokinetics of the protein. ZWI has optimized the novel polymer and begun preclinical development of protein-based therapeutics using the polymer and demonstrating reduced immunogenicity.
Speakers
Ed Mascioli, CEO - ZWI Therapeutics